NSRX — Nasus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $61.29m
- $61.29m
- 35
- 68
- 36
- 43
Annual cashflow statement for Nasus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.002 | -0.001 | -0.002 |
| Non-Cash Items | 0 | -0 | 0 |
| Discontinued Operations | |||
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.001 | 0 | 0 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -0.002 | -0.002 | -0.001 |
| Other Investing Cash Flow Items | -0 | — | — |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0 | — | — |
| Financing Cash Flow Items | -0 | 0 | -0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0.002 | 0.002 | 0.002 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -0 | 0 | 0 |